Filing Details
- Accession Number:
- 0001209191-18-027146
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-01 17:01:08
- Reporting Period:
- 2017-07-03
- Accepted Time:
- 2018-05-01 17:01:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1006045 | Iridex Corp | IRIX | Electromedical & Electrotherapeutic Apparatus (3845) | 770210467 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1601391 | Acuta Capital Fund, Lp | 1301 Shoreway Road Suite 350 Belmont CA 94002 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-08-16 | 2,260 | $8.40 | 1,343,984 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-22 | 500 | $8.42 | 1,344,484 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-25 | 236 | $8.67 | 1,344,720 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The shares were purchased in multiple transactions at prices ranging from $8.38 to $8.47 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were purchased in multiple transactions at prices ranging from $8.41 to $8.44 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were purchased in multiple transactions at prices ranging from $8.66 to $8.67 per share. The price reported reflects the volume weighted average purchase price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
